Meyka Pro banner
Perrigo Company plc

Perrigo Company plc (PRGO) Stock Overview

Explore Perrigo Company plc’s financial performance, market position, analyst ratings, and future outlook.

PRGONYSE
HealthcareDrug Manufacturers - Specialty & Generic
$14.25
$0.55(4.01%)
U.S. Market opens in 60h 44m

Perrigo Company plc (PRGO)

Meyka AI Score

Z

Key Financials

Market Cap2B
P/E Ratio-1.12
EPS (TTM)$2.50
ROE-0.56%
Fundamental Analysis

AI Price Forecasts

1 Month$13.31
3 Months$0.56
1 Year Target$1.77

PRGO Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Perrigo Company plc (NYSE: PRGO) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Perrigo Company plc's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of PRGO on the NYSE shows an RSI of 71.53, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $1.77 for the NYSE listing.

Key metrics behind Perrigo Company plc's NYSE-traded stock include a P/E ratio of -1.12 and a market capitalization of 2B. Combined with our AI analysis, these give both institutional and retail investors a clear view of PRGO on the NYSE.

Price Performance (NYSE: PRGO)

1-Day Change
3.95%
5-Day Change
11.96%
1-Month Change
36.02%
3-Month Change
25.47%
6-Month Change
-4.87%
Year-to-Date (YTD) Change
2.31%
1-Year Change
-39.22%
3-Year Change
-62.23%
5-Year Change
-65.53%
All-Time (Max) Change
144.69%

Contact Information

353 1 709 4000
The Sharp Building, Dublin, DU, D02 TY74

Company Facts

81,000 Employees
IPO DateDec 17, 1991
CountryIE
Actively Trading

Frequently Asked Questions